{"actionType":"INHIBITOR","mechanismOfAction":"Acetylcholinesterase inhibitor","chemblIds":["CHEMBL812","CHEMBL1115"],"targetName":"Acetylcholinesterase","targetType":"single protein","targets":["ENSG00000087085"],"references":[{"source":"Wikipedia","ids":["Pyridostigmine#Mode_of_action"],"urls":["http://en.wikipedia.org/wiki/Pyridostigmine#Mode_of_action"]},{"source":"DailyMed","ids":["setid=30cb0b9f-e308-4501-90c2-b17349c048b7"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=30cb0b9f-e308-4501-90c2-b17349c048b7"]}]}
{"actionType":"CHELATING AGENT","mechanismOfAction":"Calcium chelating agent","chemblIds":["CHEMBL3989529"],"references":[{"source":"DailyMed","ids":["setid=a9c1d8c5-443e-400e-a42c-16a25fb47231#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9c1d8c5-443e-400e-a42c-16a25fb47231#nlm34090-1"]},{"source":"PubMed","ids":["3828735"],"urls":["http://europepmc.org/abstract/MED/3828735"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Serotonin 2a (5-HT2a) receptor antagonist","chemblIds":["CHEMBL257704"],"targetName":"Serotonin 2a (5-HT2a) receptor","targetType":"single protein","targets":["ENSG00000102468"],"references":[{"source":"PubMed","ids":["20467592","26787771"],"urls":["http://europepmc.org/abstract/MED/20467592","http://europepmc.org/abstract/MED/26787771"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Cyclin-dependent kinase 9 inhibitor","chemblIds":["CHEMBL2103840"],"targetName":"Cyclin-dependent kinase 9","targetType":"single protein","targets":["ENSG00000136807"],"references":[{"source":"PubMed","ids":["25215591","25215591","25215591","25215591"],"urls":["http://europepmc.org/abstract/MED/25215591","http://europepmc.org/abstract/MED/25215591","http://europepmc.org/abstract/MED/25215591","http://europepmc.org/abstract/MED/25215591"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Thrombopoietin receptor agonist","chemblIds":["CHEMBL3989691","CHEMBL461101"],"targetName":"Thrombopoietin receptor","targetType":"single protein","targets":["ENSG00000117400"],"references":[{"source":"DailyMed","ids":["setid=616224ff-a925-4b38-9ca2-00fbf669380f#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=616224ff-a925-4b38-9ca2-00fbf669380f#nlm34090-1"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Glucocorticoid receptor agonist","chemblIds":["CHEMBL1200500"],"targetName":"Glucocorticoid receptor","targetType":"single protein","targets":["ENSG00000113580"],"references":[{"source":"DailyMed","ids":["setid=a0d4d864-4a45-4f1e-b3e5-d6e09b59c004#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0d4d864-4a45-4f1e-b3e5-d6e09b59c004#nlm34090-1"]}]}
{"actionType":"OTHER","mechanismOfAction":"Mucin-5AC other","chemblIds":["CHEMBL1743013"],"targetName":"Mucin-5AC","targetType":"single protein","targets":["ENSG00000215182"],"references":[{"source":"PubMed","ids":["23591984","27449137"],"urls":["http://europepmc.org/abstract/MED/23591984","http://europepmc.org/abstract/MED/27449137"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Epidermal growth factor receptor inhibitor","chemblIds":["CHEMBL4650289"],"targetName":"Epidermal growth factor receptor","targetType":"protein family","targets":["ENSG00000141736","ENSG00000146648","ENSG00000178568","ENSG00000065361"],"references":[{"source":"Other","ids":["http://www.csco.ac.cn/cat/5/show/274.html"],"urls":["http://www.csco.ac.cn/cat/5/show/274.html"]},{"source":"ClinicalTrials","ids":["NCT03574402"],"urls":["https://www.clinicaltrials.gov/ct2/show/NCT03574402"]}]}
{"actionType":"STABILISER","mechanismOfAction":"Cystic fibrosis transmembrane conductance regulator stabiliser","chemblIds":["CHEMBL2103870"],"targetName":"Cystic fibrosis transmembrane conductance regulator","targetType":"single protein","targets":["ENSG00000001626"],"references":[{"source":"FDA","ids":["label/2015/206038Orig1s000lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206038Orig1s000lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Nonstructural protein 5A inhibitor","chemblIds":["CHEMBL2374220"],"targetName":"Nonstructural protein 5A","targetType":"single protein","targets":[],"references":[{"source":"FDA","ids":["label/2014/205834s000lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205834s000lbl.pdf"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Muscarinic acetylcholine receptor M3 antagonist","chemblIds":["CHEMBL3039518"],"targetName":"Muscarinic acetylcholine receptor M3","targetType":"single protein","targets":["ENSG00000133019"],"references":[{"source":"PubMed","ids":["25100753","25629394","25100753","25629394","25100753","25629394"],"urls":["http://europepmc.org/abstract/MED/25100753","http://europepmc.org/abstract/MED/25629394","http://europepmc.org/abstract/MED/25100753","http://europepmc.org/abstract/MED/25629394","http://europepmc.org/abstract/MED/25100753","http://europepmc.org/abstract/MED/25629394"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Helicase/primase inhibitor","chemblIds":["CHEMBL4069597"],"targetName":"Helicase/primase","targetType":"protein complex","targets":[],"references":[{"source":"PubMed","ids":["24752278","29113740","24752278","29113740"],"urls":["http://europepmc.org/abstract/MED/24752278","http://europepmc.org/abstract/MED/29113740","http://europepmc.org/abstract/MED/24752278","http://europepmc.org/abstract/MED/29113740"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"PI3-kinase p110-delta subunit inhibitor","chemblIds":["CHEMBL3545068","CHEMBL3218576"],"targetName":"PI3-kinase p110-delta subunit","targetType":"single protein","targets":["ENSG00000171608"],"references":[{"source":"PubMed","ids":["15705718","24170767","15705718","24170767"],"urls":["http://europepmc.org/abstract/MED/15705718","http://europepmc.org/abstract/MED/24170767","http://europepmc.org/abstract/MED/15705718","http://europepmc.org/abstract/MED/24170767"]},{"source":"FDA","ids":["label/2017/209936s000lbl.pdf","label/2017/209936s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209936s000lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209936s000lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase SRC inhibitor","chemblIds":["CHEMBL217092"],"targetName":"Tyrosine-protein kinase SRC","targetType":"single protein","targets":["ENSG00000197122"],"references":[{"source":"PubMed","ids":["17064066","17064066"],"urls":["http://europepmc.org/abstract/MED/17064066","http://europepmc.org/abstract/MED/17064066"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Succinate semialdehyde dehydrogenase inhibitor","chemblIds":["CHEMBL2105613","CHEMBL109"],"targetName":"Succinate semialdehyde dehydrogenase","targetType":"single protein","targets":["ENSG00000112294"],"references":[{"source":"PubMed","ids":["10812195"],"urls":["http://europepmc.org/abstract/MED/10812195"]}]}
{"mechanismOfAction":"Supplement","chemblIds":["CHEMBL4297535"],"references":[{"source":"FDA","ids":["label/2018/0210589s000lbledt.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/0210589s000lbledt.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Carbonic anhydrase I inhibitor","chemblIds":["CHEMBL20"],"targetName":"Carbonic anhydrase I","targetType":"single protein","targets":["ENSG00000133742"],"references":[{"source":"PubMed","ids":["10713865","18336310","18336310","18336310","20605094"],"urls":["http://europepmc.org/abstract/MED/10713865","http://europepmc.org/abstract/MED/18336310","http://europepmc.org/abstract/MED/18336310","http://europepmc.org/abstract/MED/18336310","http://europepmc.org/abstract/MED/20605094"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Human immunodeficiency virus type 1 protease inhibitor","chemblIds":["CHEMBL1205","CHEMBL584"],"targetName":"Human immunodeficiency virus type 1 protease","targetType":"single protein","targets":[],"references":[{"source":"DailyMed","ids":["setid=e72c2bc6-9462-4a2e-8e1d-b97592376cbd"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e72c2bc6-9462-4a2e-8e1d-b97592376cbd"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine/threonine-protein kinase mTOR inhibitor","chemblIds":["CHEMBL3544963"],"targetName":"Serine/threonine-protein kinase mTOR","targetType":"single protein","targets":["ENSG00000198793"],"references":[{"source":"DOI","ids":["10.1158/1535-7163.TARG-13-C173"],"urls":["http://mct.aacrjournals.org/content/12/11_Supplement/C173"]},{"source":"Other","ids":["http://www.hra.nhs.uk/news/research-summaries/phase-1-study-of-ds-3078a-in-patients-with-advanced-cancers/"],"urls":["http://www.hra.nhs.uk/news/research-summaries/phase-1-study-of-ds-3078a-in-patients-with-advanced-cancers/"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Fatty acid synthase inhibitor","chemblIds":["CHEMBL614"],"targetName":"Fatty acid synthase","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["21835980","17101678"],"urls":["http://europepmc.org/abstract/MED/21835980","http://europepmc.org/abstract/MED/17101678"]},{"source":"Wikipedia","ids":["Pyrazinamide#Mechanism_of_action","Pyrazinamide#Mechanism_of_action"],"urls":["http://en.wikipedia.org/wiki/Pyrazinamide#Mechanism_of_action","http://en.wikipedia.org/wiki/Pyrazinamide#Mechanism_of_action"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor","chemblIds":["CHEMBL1762621"],"targetName":"Inhibitor of nuclear factor kappa B kinase beta subunit","targetType":"single protein","targets":["ENSG00000104365"],"references":[{"source":"PubMed","ids":["16998237","3542979","11043571","3542979","3542979"],"urls":["http://europepmc.org/abstract/MED/16998237","http://europepmc.org/abstract/MED/3542979","http://europepmc.org/abstract/MED/11043571","http://europepmc.org/abstract/MED/3542979","http://europepmc.org/abstract/MED/3542979"]}]}
{"actionType":"MODULATOR","mechanismOfAction":"Dopamine D2 receptor modulator","chemblIds":["CHEMBL1200707","CHEMBL1201250"],"targetName":"Dopamine D2 receptor","targetType":"single protein","targets":["ENSG00000149295"],"references":[{"source":"PubMed","ids":["22711801","6130555"],"urls":["http://europepmc.org/abstract/MED/22711801","http://europepmc.org/abstract/MED/6130555"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Integrin alpha-V/beta-3 antagonist","chemblIds":["CHEMBL429876"],"targetName":"Integrin alpha-V/beta-3","targetType":"protein complex","targets":["ENSG00000259207","ENSG00000138448"],"references":[{"source":"PubMed","ids":["12706360","21269250","12706360","21269250"],"urls":["http://europepmc.org/abstract/MED/12706360","http://europepmc.org/abstract/MED/21269250","http://europepmc.org/abstract/MED/12706360","http://europepmc.org/abstract/MED/21269250"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Reverse transcriptase inhibitor","chemblIds":["CHEMBL70663"],"targetName":"Human immunodeficiency virus type 1 reverse transcriptase","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["19029331"],"urls":["http://europepmc.org/abstract/MED/19029331"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase SYK inhibitor","chemblIds":["CHEMBL3545399"],"targetName":"Tyrosine-protein kinase SYK","targetType":"single protein","targets":["ENSG00000165025"],"references":[{"source":"PubMed","ids":["16950297"],"urls":["http://europepmc.org/abstract/MED/16950297"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Thymic stromal lymphopoietin inhibitor","chemblIds":["CHEMBL3707229"],"targetName":"Thymic stromal lymphopoietin","targetType":"single protein","targets":["ENSG00000145777"],"references":[{"source":"PubMed","ids":["28583618"],"urls":["http://europepmc.org/abstract/MED/28583618"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Focal adhesion kinase 1 inhibitor","chemblIds":["CHEMBL3137331"],"targetName":"Focal adhesion kinase 1","targetType":"single protein","targets":["ENSG00000169398"],"references":[{"source":"Other","ids":["http://www.ecmcnetwork.org.uk/sites/default/files/Verastem%20CRUK%20VS6063%2011_12_14.pdf","http://www.ecmcnetwork.org.uk/sites/default/files/Verastem%20CRUK%20VS6063%2011_12_14.pdf"],"urls":["http://www.ecmcnetwork.org.uk/sites/default/files/Verastem%20CRUK%20VS6063%2011_12_14.pdf","http://www.ecmcnetwork.org.uk/sites/default/files/Verastem%20CRUK%20VS6063%2011_12_14.pdf"]},{"source":"PubMed","ids":["25971297","26334219","25971297","26334219"],"urls":["http://europepmc.org/abstract/MED/25971297","http://europepmc.org/abstract/MED/26334219","http://europepmc.org/abstract/MED/25971297","http://europepmc.org/abstract/MED/26334219"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"Prostate specific antigen binding agent","chemblIds":["CHEMBL2108285"],"targetName":"Prostate specific antigen","targetType":"single protein","targets":["ENSG00000142515"],"references":[{"source":"PMC","ids":["PMC1476063"],"urls":["http://europepmc.org/articles/PMC1476063"]}]}
{"actionType":"NEGATIVE ALLOSTERIC MODULATOR","mechanismOfAction":"Interleukin-1 beta negative allosteric modulator","chemblIds":["CHEMBL1743026"],"targetName":"Interleukin-1 beta","targetType":"single protein","targets":["ENSG00000125538"],"references":[{"source":"PubMed","ids":["21048425"],"urls":["http://europepmc.org/abstract/MED/21048425"]}]}
{"mechanismOfAction":"Supplement","chemblIds":["CHEMBL493287"],"references":[{"source":"DailyMed","ids":["setid=8fbde87b-d0d9-4a62-b8a3-9320cbb727a5"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8fbde87b-d0d9-4a62-b8a3-9320cbb727a5"]},{"source":"PubMed","ids":["21826146","22293240"],"urls":["http://europepmc.org/abstract/MED/21826146","http://europepmc.org/abstract/MED/22293240"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"CD44 antigen binding agent","chemblIds":["CHEMBL2109288"],"targetName":"CD44 antigen","targetType":"single protein","targets":["ENSG00000026508"],"references":[{"source":"Other","ids":["https://clincancerres.aacrjournals.org/content/10/13/4363"],"urls":["https://clincancerres.aacrjournals.org/content/10/13/4363"]},{"source":"PubMed","ids":["17062682"],"urls":["http://europepmc.org/abstract/MED/17062682"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Fusion glycoprotein F0 inhibitor","chemblIds":["CHEMBL4437054"],"targetName":"Fusion glycoprotein F0","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["28761099","32201897","32407115"],"urls":["http://europepmc.org/abstract/MED/28761099","http://europepmc.org/abstract/MED/32201897","http://europepmc.org/abstract/MED/32407115"]}]}
{"actionType":"HYDROLYTIC ENZYME","mechanismOfAction":"Cholesterol ester hydrolytic enzyme","chemblIds":["CHEMBL3039537"],"references":[{"source":"FDA","ids":["label/2015/125561s000lbl.pdf","label/2015/125561s000lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125561s000lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125561s000lbl.pdf"]}]}
{"actionType":"MODULATOR","mechanismOfAction":"Progesterone receptor modulator","chemblIds":["CHEMBL2103846"],"targetName":"Progesterone receptor","targetType":"single protein","targets":["ENSG00000082175"],"references":[{"source":"PubMed","ids":["18216291"],"urls":["http://europepmc.org/abstract/MED/18216291"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Hypoxia-inducible factor prolyl hydroxylase 1 inhibitor","chemblIds":["CHEMBL3646221"],"targetName":"Hypoxia-inducible factor prolyl hydroxylase 1","targetType":"single protein","targets":["ENSG00000269858"],"references":[{"source":"Other","ids":["https://ir.akebia.com/news-releases/news-release-details/akebia-therapeutics-announces-approval-vadadustat-japan","https://ir.akebia.com/news-releases/news-release-details/akebia-therapeutics-announces-approval-vadadustat-japan","https://ir.akebia.com/news-releases/news-release-details/akebia-therapeutics-announces-approval-vadadustat-japan"],"urls":["https://ir.akebia.com/news-releases/news-release-details/akebia-therapeutics-announces-approval-vadadustat-japan","https://ir.akebia.com/news-releases/news-release-details/akebia-therapeutics-announces-approval-vadadustat-japan","https://ir.akebia.com/news-releases/news-release-details/akebia-therapeutics-announces-approval-vadadustat-japan"]},{"source":"PubMed","ids":["28242135","28928122","29435217","29485740","28242135","28928122","29435217","29485740","28242135","28928122","29435217","29485740"],"urls":["http://europepmc.org/abstract/MED/28242135","http://europepmc.org/abstract/MED/28928122","http://europepmc.org/abstract/MED/29435217","http://europepmc.org/abstract/MED/29485740","http://europepmc.org/abstract/MED/28242135","http://europepmc.org/abstract/MED/28928122","http://europepmc.org/abstract/MED/29435217","http://europepmc.org/abstract/MED/29485740","http://europepmc.org/abstract/MED/28242135","http://europepmc.org/abstract/MED/28928122","http://europepmc.org/abstract/MED/29435217","http://europepmc.org/abstract/MED/29485740"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Rho-associated protein kinase inhibitor","chemblIds":["CHEMBL3545153"],"targetName":"Rho-associated protein kinase","targetType":"protein family","targets":["ENSG00000134318","ENSG00000067900"],"references":[{"source":"PubMed","ids":["24872673"],"urls":["http://europepmc.org/abstract/MED/24872673"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Sodium/potassium-transporting ATPase inhibitor","chemblIds":["CHEMBL1614"],"targetName":"Sodium/potassium-transporting ATPase","targetType":"protein complex group","targets":["ENSG00000163399","ENSG00000129244","ENSG00000143153","ENSG00000018625","ENSG00000069849","ENSG00000105409","ENSG00000132681","ENSG00000137731"],"references":[{"source":"PubMed","ids":["16319518","23537048"],"urls":["http://europepmc.org/abstract/MED/16319518","http://europepmc.org/abstract/MED/23537048"]},{"source":"ISBN","ids":["9780702034718 PP. 258"],"urls":["http://www.isbnsearch.org/isbn/9780702034718"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"Mesothelin binding agent","chemblIds":["CHEMBL2109281"],"targetName":"Mesothelin","targetType":"single protein","targets":["ENSG00000102854"],"references":[{"source":"Other","ids":["http://en.pharmacodia.com/web/drug/1_18184.html"],"urls":["http://en.pharmacodia.com/web/drug/1_18184.html"]},{"source":"PubMed","ids":["27518442","28353637"],"urls":["http://europepmc.org/abstract/MED/27518442","http://europepmc.org/abstract/MED/28353637"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"c-Jun N-terminal kinase 3 inhibitor","chemblIds":["CHEMBL1950289"],"targetName":"c-Jun N-terminal kinase 3","targetType":"single protein","targets":["ENSG00000109339"],"references":[{"source":"PubMed","ids":["22244937","22244937","22244937"],"urls":["http://europepmc.org/abstract/MED/22244937","http://europepmc.org/abstract/MED/22244937","http://europepmc.org/abstract/MED/22244937"]}]}
{"actionType":"BLOCKER","mechanismOfAction":"Voltage-gated L-type calcium channel blocker","chemblIds":["CHEMBL1726"],"targetName":"Voltage-gated L-type calcium channel","targetType":"protein family","targets":["ENSG00000151067","ENSG00000081248","ENSG00000157388","ENSG00000102001"],"references":[{"source":"DailyMed","ids":["setid=00d506a4-74d6-4838-b008-3f9e7c017e08"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00d506a4-74d6-4838-b008-3f9e7c017e08"]},{"source":"Wikipedia","ids":["Dihydropyridine","L-type_calcium_channel","Nisoldipine","Voltage-dependent_calcium_channel"],"urls":["http://en.wikipedia.org/wiki/Dihydropyridine","http://en.wikipedia.org/wiki/L-type_calcium_channel","http://en.wikipedia.org/wiki/Nisoldipine","http://en.wikipedia.org/wiki/Voltage-dependent_calcium_channel"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Insulin receptor agonist","chemblIds":["CHEMBL1201640"],"targetName":"Insulin receptor","targetType":"single protein","targets":["ENSG00000171105"],"references":[{"source":"FDA","ids":["label/2015/022472s006s008lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022472s006s008lbl.pdf"]}]}
